FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (8 Results) - Biopharmaceuticals

Provention Bio, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, secured a term loan facility of up to $125 million with Hercules Capital.The term loan facility provides for up to $125 million of term... Read Story

September 01, 2022, 07:50 AM

Hansa Biopharma AB, (Hansa), a pioneer in enzyme technology for rare immunological conditions, has entered into an agreement with U.S.-based NovaQuest Capital Management, securing $70 million in non-dilutive financing."This transaction, which extends... Read Story

July 21, 2022, 07:45 AM

Savara, a clinical stage biopharmaceutical company focused on rare respiratory diseases, entered into a term loan agreement of $26.5 million with Silicon Valley Bank to replace its existing credit facility with the bank. The new facility represents a... Read Story

April 25, 2022, 07:29 AM

BioXcel Therapeutics, a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, announced strategic financing agreements with funds managed by... Read Story

April 20, 2022, 07:40 AM

Xeris Biopharma Holdings entered into a senior secured term loan agreement with funds managed by Hayfin Capital Management to provide Xeris with up to a total of $150 million of capital.Under the terms of the debt facility, Xeris drew down $100... Read Story

March 10, 2022, 07:49 AM

Ardelyx, a biopharmaceutical company, announced it has entered into a debt financing agreement with investment affiliates managed by SLR Capital Partners."We are pleased to enter into this agreement with SLR for non-dilutive capital ahead of an... Read Story

February 25, 2022, 08:03 AM

Amryt, a global, commercial-stage biopharmaceutical company secured $125 million of senior credit facilities from funds managed by the Credit Group of Ares Management Corporation. Amryt will use a portion of the proceeds to refinance its previous... Read Story

February 23, 2022, 07:18 AM

Corium, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, closed on a $235 million term loan agreement with Hercules Capital. Corium will receive an initial... Read Story

September 29, 2021, 07:32 AM